Exceptional Responders Clinical Trials Eligibility and Early Results
Henry Mark Kuerer, MD, PhD, FACS, CMP and Melissa P. Mitchell, MD
MD Anderson Cancer Center - University of Texas

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Define eligibility and early results for the cohort A clinical trial for eliminating surgery after neoadjuvant systemic therapy for breast cancer
• Define eligibility and early results for the cohort C clinical trial for eliminating radiotherapy after neoadjuvant systemic therapy for breast cancer

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly.Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. Attendance must be manually recorded in MedHub. Contact MSCGME support staff for assistance.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.